ENDV (Endonovo Therapeutics) Common Stock: $0.12 Mil (As of Jun. 2025)


What is Endonovo Therapeutics Common Stock?

Endonovo Therapeutics ENDV -99.00% Common Stock is $0.12 Mil as of Jun. 2025. The stock has 3 warning signs investors should review.

Endonovo Therapeutics's quarterly common stock increased from Dec. 2024 ($0.05 Mil) to Mar. 2025 ($0.11 Mil) and increased from Mar. 2025 ($0.11 Mil) to Jun. 2025 ($0.12 Mil).

Endonovo Therapeutics's annual common stock increased from Dec. 2022 ($0.02 Mil) to Dec. 2023 ($0.03 Mil) and increased from Dec. 2023 ($0.03 Mil) to Dec. 2024 ($0.05 Mil).

Endonovo Therapeutics Common Stock Historical Data

* Premium members only.

The historical data trend for Endonovo Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endonovo Therapeutics Common Stock Chart

Endonovo Therapeutics Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.01 0.02 0.03 0.05

Endonovo Therapeutics Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.04 0.04 0.05 0.11 0.12

Endonovo Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.12 Mil mean?
Endonovo Therapeutics (ENDV) has a Common Stock of $0.12 Mil as of Jun. 2025. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Endonovo Therapeutics and its competitors.
Is Endonovo Therapeutics' Common Stock too high?
Endonovo Therapeutics' current Common Stock is $0.12 Mil.
How does Endonovo Therapeutics' Common Stock compare to RGBP and IOBTQ?
Endonovo Therapeutics' Common Stock of $0.12 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Endonovo Therapeutics and its competitors. Endonovo Therapeutics's current Common Stock is $0.12 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Endonovo Therapeutics stock overvalued right now?
Endonovo Therapeutics (ENDV) has a current Common Stock of $0.12 Mil. The current Common Stock is $0.12 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Endonovo Therapeutics (ENDV), the current Common Stock is $0.12 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Endonovo Therapeutics Business Description

Address 6320 Canoga Avenue, 15th Floor, Woodland Hills, CA, USA, 91367
Endonovo Therapeutics Inc develops, manufactures and distributes revolutionary medical devices that utilize Pulsed Electro Magnetic Field (PEMF) therapy that are focused on the rapid recovery of wounds and reduction of pain, edema and inflammation on and in the human body.